Sam Brusco, Associate Editor12.04.23
BD (Becton, Dickinson and Company) has launched a new, advanced ultrasound system—SiteRite 9. The system aims to boost efficiency when placing PICCs, central venous catheters, and IV lines.
SiteRite 9, according to BD, is an all-in-one system with an updated 15.6-inch touch screen with enhanced image quality. It offers catheter placement tools to help clinicians during the vascular device insertion process.
BD’s Cue needle tracking gives nurses continuous, real-time tracking and the Sherlock 3CG+ tip confirmation helps ensure proper catheter tip navigation and location.
"Our latest innovation in ultrasound technology is designed to make vascular access care delivery easier and more efficient for clinicians—whether they've been on the job for years or are new to the field," said Eric Borin, worldwide president of Medication Delivery Solutions at BD. "By combining our decades of leadership in vascular access with voice-of-the-customer enhancements, we've developed a best-in-class solution to aid in insertion success on the first attempt and reduce the need for repeated needlesticks to deliver a better care experience for everyone involved."
SiteRite 9 also touts vessel assessment tools that automatically detect the vessel, then pair with vessel measurement tools to help choose the appropriate catheter. Other capabilities include patient data look up with information capture, auto-filling, and records transfer.
SiteRite 9 received 510(k) clearance in September and is now commercially available to U.S. customers.
Earlier this month, BD hired 3M Health Care executive Dr. Ron Silverman as its new chief medical officer.
SiteRite 9, according to BD, is an all-in-one system with an updated 15.6-inch touch screen with enhanced image quality. It offers catheter placement tools to help clinicians during the vascular device insertion process.
BD’s Cue needle tracking gives nurses continuous, real-time tracking and the Sherlock 3CG+ tip confirmation helps ensure proper catheter tip navigation and location.
"Our latest innovation in ultrasound technology is designed to make vascular access care delivery easier and more efficient for clinicians—whether they've been on the job for years or are new to the field," said Eric Borin, worldwide president of Medication Delivery Solutions at BD. "By combining our decades of leadership in vascular access with voice-of-the-customer enhancements, we've developed a best-in-class solution to aid in insertion success on the first attempt and reduce the need for repeated needlesticks to deliver a better care experience for everyone involved."
SiteRite 9 also touts vessel assessment tools that automatically detect the vessel, then pair with vessel measurement tools to help choose the appropriate catheter. Other capabilities include patient data look up with information capture, auto-filling, and records transfer.
SiteRite 9 received 510(k) clearance in September and is now commercially available to U.S. customers.
Earlier this month, BD hired 3M Health Care executive Dr. Ron Silverman as its new chief medical officer.